Study uncovers new Alzheimer’s genes, links to immune disruption
Alzheimer's disease, clinical trials, genetics, immunology, neurology, R&D
0 Comment
genetics
Sano raises $11m for patient and trial matchmaking platform
clinical research, clinical trials, financing, genetics, patient recruitment, Sano Genetics
0 Comment
Explore the latest developments in ATMPs at Cell & Gene Therapy 2018
cell, gene therapy, genetics, genomics, rna
0 Comment
Cell & Gene Therapy 2018
Nebula wants to democratise genome sequencing, with the help of blockchain and cryptocurrency
Blockchain, cryptocurrency, genetics, genome sequencing, genomics
0 Comment
A new start-up has been launched with a dazzling, technology-enabled vision of putting genomics into the hands of the DNA’s owners – individuals – rather than what it calls genomics ‘middle men’.
Oxford Nanopore’s tech reaches genome sequencing landmark
cancer, cystic fibrosis, digital health, genetics, Illumina, medical devices, nanopore, Oxford Nanopore
0 Comment
Oxford Nanopore one of many firms cutting time and cost of sequencing
Lundbeck trial investigates genetic causes of depression
depression, genetics, Lundbeck, R&D
0 Comment
New study with 23andMe and Milken Institute looks to determine causes of depression.
Hospital uses AI to embrace clinical genomics
AI, artificial intelligence, data-driven medicine, genetics, genomics, Sophia Genetics, St George's Hospital
0 Comment
AI can sift and analyse vast amounts of genomic data, enabling clinical scientists to better diagnose patients.
FDA approval for 23andMe’s direct-to-consumer genetics test
23andMe, fda, genetics, hereditary testing
0 Comment
Service can now be marketed as test for Alheimer’s and Parkinson’s, among others.
1 2